Roshni Ravindranathan

Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy

Zuqiang Liu, Roshni Ravindranathan, Paweł Kaliński et al. · Nature Communications · 2017 · 346 citations · Full text

Medicine, Immunology, Oncology +17

Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers

Stephanie Downs‐Canner, Zong Sheng Guo, Roshni Ravindranathan et al. · Molecular Therapy · 2016 · 143 citations · Full text

Life Sciences, Immunology, Oncology +17

Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade

Stacy J. Kowalsky, Zuqiang Liu, Mathilde Feist et al. · Molecular Therapy · 2018 · 141 citations · Full text

Medicine, Immunology, Oncology +17

CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy

Zuqiang Liu, Roshni Ravindranathan, Jun Li et al. · OncoImmunology · 2015 · 112 citations · Full text

Medicine, Immunology, Oncology +17

Oncolytic virus promotes tumor-reactive infiltrating lymphocytes for adoptive cell therapy

Mathilde Feist, Zhi Zhu, Enyong Dai et al. · Cancer Gene Therapy · 2020 · 53 citations · Full text

Medicine, Immunology, Oncology +16